Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Overall signal: Reviews summarize broad preclinical benefits but emphasize minimal human data and the need for trials before clinical adoption
Metabolic Pharmaceuticals terminated development for obesity in February 2007
10.1046/j.1365-2125.2003.01907.x 53 SterneJ.HernnM.ReevesB.SavoviJ.BerkmanN.ViswanathanM.et al (2016)
As your body ages, it becomes less efficient at breaking down micronutrients and delivering them where they are most needed
This suppression reduces production of pro-inflammatory cytokines including TNF-alpha, IL-6, and IL-1, creating an environment more conducive to tissue repair
It has been evaluated in clinical and preclinical models for its ability to modulate dopamine, norepinephrine, and serotonin signaling pathways associated with metabolic and neurological research.
US$ 25.88
US$ 22.31
US$ 26.69
US$ 21.77
US$ 28.95
US$ 25.44
US$ 23.68
US$ 22.13
US$ 27.82
